Assessing alveolar rhabdomyosarcoma cell lines as tumor models by comparison of mRNA expression profiles
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and PitfallsFrontiers in Oncology, 2013
- p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast CancerCancer Cell, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivoBritish Journal of Cancer, 2010
- Gene ontology analysis for RNA-seq: accounting for selection biasGenome Biology, 2010
- Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975‐2005Cancer, 2009
- TP53 Status and Response to Chemotherapy in Breast CancerPathobiology, 2008
- Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide RegimenPLOS Medicine, 2007
- Properties of voltage-gated Na+ channels in the human rhabdomyosarcoma cell-line SJ-RH30: Conventional and automated patch clamp analysisPharmacological Research, 2006
- p53 and cancer therapy: a double-edged swordJournal of Clinical Investigation, 1999